Evidence map›Paper›PMID 19789384›Full record

ReviewPhysiological reviews2009

Reward processing by the opioid system in the brain.

Julie Le Merrer, Jérôme A J Becker, Katia Befort, Brigitte L Kieffer

Registry-linked trialAbstract readReview
In one paragraph

Review in Physiological reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03161795 (Addressing the Risks of Long-Term Opioid Therapy in Chronic Noncancer Pain), which is not on this map. Cited by 504 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
504citing papers in PubMed, 1 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03161795 completednot on this mapstarted 2017, after this paper: background citation

Addressing the Risks of Long-Term Opioid Therapy in Chronic Noncancer Pain: A National, Multicenter, and Observational Cross-sectional Study in South Korea

Typeobservational_patient_registrySponsorSeoul National UniversityRan2017 to 2018Enrolled258ConditionsChronic Noncancer Pain, Opioid-Related Disorders
3 · Its place in the literature

Who cites it

504 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,002 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A widespread internal brain state for fentanyl withdrawal.bioRxiv : the preprint server for biology · 2026
    Article
  19. Article
  20. An emerging role for synaptic ZnPharmacology & therapeutics · 2026
    Review

444 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Julie Le MerrerInstitut de Génétique et de Biologie Moléculaire et Cellulaire, Département Neurobiologie et Génétique, Illkirch, France.
Jérôme A J Becker
Katia Befort
Brigitte L Kieffer
Institut de Biologie Moléculaire et Cellulaire · FRInstitut de génétique et de biologie moléculaire et cellulaire · FR

Funding

The Role of Striosome Neurons in Mediating Opiod RewardP50DA005010 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FANSELOW, MICHAEL S · 1987 to 2021
$30.7M
Nr4a1 and GPR88 as novel gene targets for alcoholism: mouse genetic approachesU01AA016658 · NIAAA · UNIVERSITE DE STRASBOURG · PI LAURA ADELA HARSAN · 2006 to 2026
$3.8M
VULNERABILITY TO NICOTINE ADDICTIONR01DA016768 · NIDA · POMPEU FABRA UNIVERSITY · PI MALDONADO, RAFAEL · 2004 to 2008
$1.5M
NIAAA NIH HHS AA-16658NIAAA NIH HHS U01 AA016658NIDA NIH HHS DA-05010NIDA NIH HHS DA-16768NIDA NIH HHS P50 DA005010NIDA NIH HHS R01 DA016768
6 · The paper itself

Abstract

The opioid system consists of three receptors, mu, delta, and kappa, which are activated by endogenous opioid peptides processed from three protein precursors, proopiomelanocortin, proenkephalin, and prodynorphin. Opioid receptors are recruited in response to natural rewarding stimuli and drugs of abuse, and both endogenous opioids and their receptors are modified as addiction develops. Mechanisms whereby aberrant activation and modifications of the opioid system contribute to drug craving and relapse remain to be clarified. This review summarizes our present knowledge on brain sites where the endogenous opioid system controls hedonic responses and is modified in response to drugs of abuse in the rodent brain. We review 1) the latest data on the anatomy of the opioid system, 2) the consequences of local intracerebral pharmacological manipulation of the opioid system on reinforced behaviors, 3) the consequences of gene knockout on reinforced behaviors and drug dependence, and 4) the consequences of chronic exposure to drugs of abuse on expression levels of opioid system genes. Future studies will establish key molecular actors of the system and neural sites where opioid peptides and receptors contribute to the onset of addictive disorders. Combined with data from human and nonhuman primate (not reviewed here), research in this extremely active field has implications both for our understanding of the biology of addiction and for therapeutic interventions to treat the disorder.

Indexed as

RewardAnimalsBrainEndorphinsHumansReceptors, OpioidReinforcement, PsychologyRNA, MessengerSubstance-Related DisordersEndorphinsReceptors, OpioidRNA, Messenger

Identifiers

PMID19789384
PMCPMC4482114
OpenAlexW2129143684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.